Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -2.59% | 204.73 | 0.0% | $1953.60m | |
| NVAX | Novavax, Inc. | -1.39% | 110.82 | 78.2% | $804.64m | |
| AMGN | Amgen, Inc. | 1.95% | 235.36 | 1.4% | $611.59m | |
| BIIB | Biogen, Inc. | 1.11% | 239.30 | 1.8% | $512.74m | |
| GILD | Gilead Sciences, Inc. | -0.15% | 71.77 | 1.0% | $503.51m | |
| BNTX | BioNTech SE | -3.44% | 196.00 | 0.0% | $496.41m | |
| ILMN | Illumina, Inc. | 1.41% | 405.14 | 3.3% | $455.30m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.14% | 615.24 | 2.7% | $435.16m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 3.30% | 234.06 | 1.9% | $373.05m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 2.26% | 3.17 | 0.7% | $221.59m | |
| INCY | Incyte Corp. | 1.67% | 74.88 | 2.4% | $172.85m | |
| EXAS | EXACT Sciences Corp. | 4.02% | 78.43 | 18.0% | $156.45m | |
| ARNA | Arena Pharmaceuticals, Inc. | 0.20% | 92.65 | 13.7% | $151.27m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.34% | 148.50 | 8.2% | $147.48m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 2.34% | 90.22 | 4.2% | $114.62m |
Company Profile
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine) and Selincro (nalmefene). The firm's also offers Research and Development Programs like ARCUS for acute migraine, Cimaglermin alfa and rHIgM22. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.